Completed
The National Cancer Policy Forum held a public workshop to examine strategies for widening the spectrum of precompetitive collaboration in biomedical oncology research and development. Over the last decade, biomedical research and drug development costs have skyrocketed, despite falling productivity evidenced by increasing drug development timelines and decreasing new molecular entity approvals. Increased precompetitive collaboration is a potential solution to drive innovation and improve productivity. Workshop presentations and discussions characterized the precompetitive collaboration environment and provided examples of precompetitive collaboration in science, biomedicine, and oncology.
Featured publication
Workshop
·2010
Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no...
View details
Description
The National Cancer Policy Forum intends to sponsor a public workshop addressing the widening spectrum of competitive and precompetitive collaboration in oncology biomedical research and development. An ad hoc committee will plan and conduct the workshop, whose agenda will cover the roles different types of collaboration in oncology, detailed examples, and future directions. The workshop, which will be held at an open meeting of the Forum in 2010, will feature invited presentations and discussion, and will serve to inform the Forum and the IOM. An individually-authored summary of the workshop will subsequently be prepared by a designated rapporteur.
Collaborators
Sponsors
American Cancer Society
American Society of Clinical Oncology
Association of American Cancer Institutes
C-Change
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
National Cancer Institute
Major units and sub-units
Center for Health, People, and Places
Lead
Institute of Medicine
Lead
Board on Health Care Services
Lead
Board on Health Sciences Policy
Lead
Health Care and Public Health Program Area
Lead
Biomedical and Health Sciences Program Area
Lead
